NEKTAR THERAPEUTICS's ticker is and the CUSIP is 640268908. A total of 5 filers reported holding NEKTAR THERAPEUTICS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $117,000 | -15.8% | 36,600 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $139,000 | -94.1% | 36,600 | -91.6% | 0.01% | -89.5% |
| Q1 2022 | $2,344,000 | -66.9% | 434,900 | -17.1% | 0.08% | -70.4% |
| Q4 2021 | $7,090,000 | +16.9% | 524,800 | +55.5% | 0.26% | +38.9% |
| Q3 2021 | $6,063,000 | – | 337,600 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 36,600 | $139,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 178,700 | $679,000 | 0.00% |
| SIMPLEX TRADING, LLC | 245,500 | $932,000 | 0.00% |
| JANE STREET GROUP, LLC | 160,000 | $608,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |